Unitree Robotics has reported that the cumulative deviation in its stock closing prices over three consecutive trading days has surpassed 30%, signaling abnormal volatility in its stock trading. Presently, the humanoid robot industry is firmly entrenched in the early stages of commercialization, characterized by uncertainties surrounding technological readiness, downstream market demand, and supply chain proficiency. Should the industry's large-scale commercialization fail to meet expectations, the company's future revenue streams and performance metrics could be significantly impacted, thereby introducing the potential for valuation adjustments.
